Hims & Hers Health, Inc. HIMS

FY2025 · ended Dec 31, 2025 · Revenue $2.35B, +59.0% YoY · Filed Feb 23, 2026

Hims & Hers Health, Inc. (HIMS) files with the SEC under industry code 8011, Services-Offices & Clinics of Doctors of Medicine. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.3 billion and net income of $128.4 million. Free cash flow was $57.4 million. As of Jun 30, 2026 it held $841.0 million in cash and investments and $180.9 million in total debt.

Revenue (TTM)
$2.58B
+28.0% vs year-ago TTM
Net income (TTM)
$-142.03M
-173.4% vs year-ago TTM
Operating cash flow (TTM)
$263.45M
+0.7% vs year-ago TTM
Free cash flow (TTM)
$61.65M
EPS (TTM)
$-0.57
-173.0% vs year-ago TTM
Dividend per share
None
Shares outstanding
—
Net cash
$660.11M
as of Jun 30, 2026
Operating margin
-6.0%
FY 2026

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
HIMS (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1773751
Former names
Oaktree Acquisition Corp. (until Jan 19, 2021)

Other Services-Offices & Clinics of Doctors of Medicine companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$2.3B
$1.5B
$872.0M
$526.9M
$271.9M
Operating income
$105.6M
$61.9M
-$29.5M
-$68.7M
-$115.0M
Net income
$128.4M
$126.0M
-$23.5M
-$65.7M
-$107.7M
Diluted EPS
$0.51
$0.53
-$0.11
-$0.32
-$0.58
Operating cash flow
$300.0M
$251.1M
$73.5M
-$26.5M
-$34.4M
Free cash flow
$57.4M
$198.3M
—
—
—
Total assets
$2.2B
$707.5M
$441.2M
$366.3M
$420.6M
Total liabilities
$1.6B
$230.8M
$97.2M
$54.6M
$86.0M
Stockholders' equity
$540.9M
$476.7M
$344.0M
$311.7M
$334.6M
Cash and investments
$928.8M
$300.3M
$221.0M
$179.6M
$247.3M
Total debt
$148.0M
$11.3M
$9.9M
$5.3M
$5.5M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 7, 2026 Oct 7, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Officer or director change
Jul 17, 2026 Jul 13, 2026
8-K Current report
Material agreement, New debt
Jul 1, 2026 Jun 26, 2026
8-K Current report
Shareholder vote results
Jun 15, 2026 Jun 11, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.